Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Rab5b | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of RAB5B mRNA | CTD | PMID:22206623 | Rab5b | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Rab5b | Rat | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Rab5b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RAB5B mRNA | CTD | PMID:21215274 and PMID:33387578 | Rab5b | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rab5b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAB5B mRNA | CTD | PMID:21570461 | Rab5b | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of RAB5B mRNA | CTD | PMID:20188158 | Rab5b | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | Rab5b | Rat | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of RAB5B mRNA | CTD | PMID:19162173 | Rab5b | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of RAB5B mRNA | CTD | PMID:18648102 | Rab5b | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | Rab5b | Rat | acrylamide | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | Acrylamide results in decreased expression of RAB5B mRNA | CTD | PMID:30807115 | Rab5b | Rat | benzo[a]pyrene | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of RAB5B mRNA | CTD | PMID:22228805 | Rab5b | Rat | benzo[e]pyrene | decreases methylation | ISO | RAB5B (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of RAB5B intron | CTD | PMID:30157460 | Rab5b | Rat | beta-lapachone | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of RAB5B mRNA | CTD | PMID:38218311 | Rab5b | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RAB5B mRNA | CTD | PMID:25181051 | Rab5b | Rat | bisphenol A | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | bisphenol A results in increased expression of RAB5B protein | CTD | PMID:34186270 and PMID:37567409 | Rab5b | Rat | bisphenol A | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RAB5B mRNA | CTD | PMID:33221593 | Rab5b | Rat | bisphenol F | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | Rab5b | Rat | bisphenol F | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | bisphenol F results in increased expression of RAB5B mRNA | CTD | PMID:38685157 | Rab5b | Rat | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of RAB5B promoter | CTD | PMID:22457795 | Rab5b | Rat | cadmium dichloride | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of RAB5B protein | CTD | PMID:24527689 | Rab5b | Rat | carbon nanotube | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of RAB5B mRNA | CTD | PMID:25554681 | Rab5b | Rat | chlordecone | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | Chlordecone results in increased expression of RAB5B mRNA | CTD | PMID:33711761 | Rab5b | Rat | choline | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA | CTD | PMID:20938992 | Rab5b | Rat | cisplatin | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of RAB5B mRNA | CTD | PMID:27594783 | Rab5b | Rat | cisplatin | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Cisplatin results in increased expression of RAB5B mRNA | CTD | PMID:27392435 | Rab5b | Rat | cytarabine | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Cytarabine results in increased expression of RAB5B mRNA | CTD | PMID:19194470 | Rab5b | Rat | DDE | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of RAB5B mRNA | CTD | PMID:38568856 | Rab5b | Rat | dexamethasone | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | Rab5b | Rat | diquat | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | Diquat results in decreased expression of RAB5B protein | CTD | PMID:36851058 | Rab5b | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of RAB5B mRNA | CTD | PMID:21551480 | Rab5b | Rat | fluvastatin | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [zoledronic acid co-treated with fluvastatin] results in increased expression of RAB5B mRNA | CTD | PMID:16996129 | Rab5b | Rat | folic acid | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA | CTD | PMID:20938992 | Rab5b | Rat | glyphosate | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Glyphosate results in increased expression of RAB5B mRNA | CTD | PMID:31295307 | Rab5b | Rat | hexane | decreases methylation | EXP | | 6480464 | n-hexane results in decreased methylation of RAB5B promoter | CTD | PMID:23740543 | Rab5b | Rat | indometacin | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RAB5B mRNA | CTD | PMID:28628672 | Rab5b | Rat | ivermectin | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RAB5B protein | CTD | PMID:32959892 | Rab5b | Rat | L-methionine | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA | CTD | PMID:20938992 | Rab5b | Rat | leflunomide | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | leflunomide results in decreased expression of RAB5B mRNA | CTD | PMID:28988120 | Rab5b | Rat | methapyrilene | decreases methylation | ISO | RAB5B (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of RAB5B intron | CTD | PMID:30157460 | Rab5b | Rat | N-methyl-4-phenylpyridinium | affects expression | ISO | RAB5B (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium affects the expression of RAB5B mRNA | CTD | PMID:12710931 | Rab5b | Rat | nickel dichloride | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | nickel chloride results in decreased expression of RAB5B mRNA | CTD | PMID:17312168 | Rab5b | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RAB5B mRNA | CTD | PMID:33387578 | Rab5b | Rat | PCB138 | multiple interactions | ISO | Rab5b (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Rab5b | Rat | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of RAB5B mRNA | CTD | PMID:19162173 | Rab5b | Rat | pirinixic acid | decreases expression | ISO | Rab5b (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of RAB5B mRNA | CTD | PMID:20813756 | Rab5b | Rat | potassium dichromate | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of RAB5B protein | CTD | PMID:23718831 | Rab5b | Rat | resveratrol | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | resveratrol results in increased expression of RAB5B protein | CTD | PMID:25505154 | Rab5b | Rat | resveratrol | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of RAB5B mRNA | CTD | PMID:23557933 | Rab5b | Rat | SB 431542 | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAB5B protein | CTD | PMID:37664457 | Rab5b | Rat | silver atom | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Silver results in decreased expression of RAB5B mRNA | CTD | PMID:26551752 | Rab5b | Rat | silver(0) | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Silver results in decreased expression of RAB5B mRNA | CTD | PMID:26551752 | Rab5b | Rat | sodium arsenate | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | sodium arsenate results in increased expression of RAB5B mRNA | CTD | PMID:21795629 | Rab5b | Rat | sodium arsenite | increases expression | ISO | RAB5B (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of RAB5B mRNA | CTD | PMID:38568856 | Rab5b | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of RAB5B mRNA | CTD | PMID:31150632 | Rab5b | Rat | titanium dioxide | increases expression | ISO | Rab5b (Mus musculus) | 6480464 | titanium dioxide results in increased expression of RAB5B mRNA | CTD | PMID:29264374 | Rab5b | Rat | titanium dioxide | decreases methylation | ISO | Rab5b (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of RAB5B gene | CTD | PMID:35295148 | Rab5b | Rat | titanium dioxide | increases methylation | ISO | Rab5b (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of RAB5B gene | CTD | PMID:35295148 | Rab5b | Rat | triphenyl phosphate | affects expression | ISO | RAB5B (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of RAB5B mRNA | CTD | PMID:37042841 | Rab5b | Rat | valproic acid | decreases expression | ISO | RAB5B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of RAB5B mRNA | CTD | PMID:23179753 | Rab5b | Rat | valproic acid | affects expression | ISO | RAB5B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RAB5B mRNA | CTD | PMID:25979313 | Rab5b | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of RAB5B mRNA | CTD | PMID:19015723 | Rab5b | Rat | zoledronic acid | multiple interactions | ISO | RAB5B (Homo sapiens) | 6480464 | [zoledronic acid co-treated with fluvastatin] results in increased expression of RAB5B mRNA | CTD | PMID:16996129 | |